Short interest on LFST sees a significant increase on 2025-12-31

Samantha Gray

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. LifeStance Health Group Inc shares valued at $844,392 were sold by Bessler Robert on Dec 19 ’25. At $7.04 per share, Bessler Robert sold 119,942 shares. The insider’s holdings dropped to 1,318,983 shares worth approximately $9.51 million following the completion of this transaction.

Also, Bessler Robert sold 1,701 shares, netting a total of over 11,975 in proceeds. Following the sale of shares at $7.04 each, the insider now holds 1,318,133 shares.

Before that, Bessler Robert had added 1,701 shares to its account. In a trade valued at $11,975, the Director bought LifeStance Health Group Inc shares for $7.04 each.

As published in their initiating research note from Barclays on December 09, 2025, LifeStance Health Group Inc [LFST] has been an Overweight and the price target has been revised to $8. Analysts at BMO Capital Markets started covering the stock with ‘”an Outperform”‘ outlook in a report released in mid November. As of July 25, 2025, BTIG Research has initiated its “Buy” rating for LFST. Earlier on May 27, 2025, UBS upgraded its rating. Their new recommendation was “a Buy” for LFST stock which previously was a “a Neutral”.

Analyzing LFST Stock Performance

On last trading session, LifeStance Health Group Inc [NASDAQ: LFST] rose 0.42% to $7.21. The stock’s lowest price that day was $7.1, but it reached a high of $7.275 in the same session. During the last five days, there has been a drop of approximately -0.55%. Over the course of the year, LifeStance Health Group Inc shares have dropped approximately -9.76%.

Is LifeStance Health Group Inc subject to short interest?

Stocks of LifeStance Health Group Inc saw a sharp rise in short interest on 2025-12-31 jumping by 62836.0 shares to 8.19 million. Data from Yahoo Finance shows that the short interest on 2025-11-28 was 8.13 million shares. A jump of 0.77% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 3.63 of the overall float, the days-to-cover ratio (short ratio) jumped to 3.63.

Which companies own the most shares of LifeStance Health Group Inc (LFST)?

In terms of LifeStance Health Group Inc share price expectations, FactSet research, analysts set an average price target of 8.75 in the next 12 months, up nearly 21.87% from the previous closing price of $7.18. Analysts anticipate LifeStance Health Group Inc stock to reach 10 by 2026, with the lowest price target being 8. In spite of this, 4 analysts ranked LifeStance Health Group Inc stock as Buy at the end of 2026. On April 08, 2025, KeyBanc Capital Markets assigned a price target of “an Overweight” to the stock and initiated coverage with a $9.

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.